Actis Exits Glenmark Pharmaceuticals
10/31/06, 4:41 PMAnother private equity fund exit is here. Actis has sold its existing 6.7 per cent stake in Glenmark Pharmaceuticals for Rs 304 crore to HSBC Global Investment Fund. The deal has been struck at Rs 380 a share.
Actis invested ($10.2 million) in the company in 2002. In September ’03, it held a total stake of [...]


